Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Gender disparities in patients with melanoma: breaking the glass ceiling.

Literature DB >> 22547593

Gender disparities in patients with melanoma: breaking the glass ceiling.

Vernon K Sondak, Susan M Swetter, Marianne A Berwick.

Abstract

Entities: Disease Species

Mesh：

Year: 2012 PMID： 22547593 DOI： 10.1200/JCO.2011.41.3849

Source DB: PubMed Journal: J Clin Oncol ISSN： 0732-183X Impact factor: 44.544

Keyword Cloud
Cited

× No keyword cloud information.

7 in total

1. Prevalence and predictors of recent skin examination in a population-based twin cohort.

Authors: Kimberly A Miller; Bryan M Langholz; John Zadnick; Ann S Hamilton; Wendy Cozen; Thomas M Mack; Myles G Cockburn
Journal: Cancer Epidemiol Biomarkers Prev Date: 2015-05-20 Impact factor: 4.254

2. A cancer registry-based analysis on the non-white populations reveals a critical role of the female sex in early-onset melanoma.

Authors: Tze-An Yuan; Frank Meyskens; Feng Liu-Smith
Journal: Cancer Causes Control Date: 2018-03-09 Impact factor: 2.506

3. Sentinel lymph node biopsy is indicated for patients with thick clinically lymph node-negative melanoma.

Authors: Maki Yamamoto; Kate J Fisher; Joyce Y Wong; Jonathan M Koscso; Monique A Konstantinovic; Nicholas Govsyeyev; Jane L Messina; Amod A Sarnaik; C Wayne Cruse; Ricardo J Gonzalez; Vernon K Sondak; Jonathan S Zager
Journal: Cancer Date: 2015-02-11 Impact factor: 6.860

Gender disparities in patients with melanoma: breaking the glass ceiling.

1. Prevalence and predictors of recent skin examination in a population-based twin cohort.

2. A cancer registry-based analysis on the non-white populations reveals a critical role of the female sex in early-onset melanoma.

3. Sentinel lymph node biopsy is indicated for patients with thick clinically lymph node-negative melanoma.

4. Impact of gender and primary tumor location on outcome of patients with cutaneous melanoma.

5. Neutrophil-to-lymphocyte Ratio (NLR) as a predictor for recurrence in patients with stage III melanoma.

6. Molecular Cytogenetic Study of the NF2 Gene Deletion in Meningioma in Sudanese Patients.

7. Differences in cutaneous melanoma treatment and patient satisfaction.